Randomized Trial of Anti-VEGF to Prevent Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME)

Randomized Trial of Anti-VEGF to Prevent Prol...

Up next

Diabetes Severity in Cornea Donors and 1-Year Outcomes in Recipients

Interview with Jonathan H. Lass, MD, author of Diabetes Severity in Cornea Donors and 1-Year Outcomes in Recipients in the Diabetes Endothelial Keratoplasty Study: A Secondary Analysis of a Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content: Diabetes Severity ...  Show more

Why Metrics Matter in Thyroid Eye Disease

Interview with Michael Kazim, MD, author of Why Metrics Matter in Thyroid Eye Disease: An Innovate TED Initiative. Hosted by Neil Bressler, MD. Related Content: Why Metrics Matter in Thyroid Eye Disease 

Recommended Episodes

Anti-VEGF vs Panretinal Photocoagulation Laser Therapy for Diabetic Retinopathy
Ophthalmology Journal

<span style= "color: black; mso-themecolor: text1;">Dr. Rajesh Rao sits down with Dr. Sophie J. Bakri and medical student Marie-Michele Macaron to discuss their systematic Review and meta-analysis on the efficacy and safety of anti-VEGF and panretinal photoco ...

  Show more

Epiretinal Membrane in Diabetic Patients
Ophthalmology Journal

Dr. Rajesh Rao discusses the risk factors for epiretinal membrane formation in patients with diabetes mellitus with Dr. Shinji Kakihara, first author of the Ophthalmology Science article, "Epiretinal Membrane Is Associated with Diabetic Retinopathy Severity and Cumulative Anti-VE ...  Show more

Therapeutic Interventions for Autoimmune Retinopathy
Ophthalmology Journal

Dr. Edmund Tsui is joined by Dr. Majda Hadziahmetovic to discuss her meta-analysis and systematic review investigating the effectiveness of systemic and local treatments in slowing autoimmune retinopathy progression. From the Ophthalmology Science article, "< ...

  Show more

Common Medications and Diabetic Macular Edema
Ophthalmology Journal

Dr. Drew Carey interviews medical student Jawad Muayad and Dr. Sami S. Dahr on the impact of systemic medications, including glucagon-like peptide-1 receptor agonists, fenofibrates, thiazolidinediones, and calcium channel blockers, on the risk of developing diabetic macular edema ...  Show more